The organisations building Gulf biotechnology
Explore the companies, research platforms, manufacturers and ecosystem organisations shaping the sector.
Companies, platforms and ecosystem operators tracked
Gulf-founded companies, state platforms, spinouts and foreign operators, kept distinct.
Every filled cell traces to a published source, and blank cells are filled as sources publish. Patent positions are recorded where a specific filing or grant has been published, and owned patent positions are the next milestone across the tracker. A next milestone is listed where it is specific to that organisation; where the next step is shared by a whole class of company, the column stays concise rather than repeating itself. Cohort membership in an accelerator records selection; funding, revenue, approval and intellectual property are recorded separately as each is published.
Data table
| Organisation | Market | Type | Stage | Intellectual property | Source |
|---|---|---|---|---|---|
| LiferaContract development and manufacturing across sterile and aseptic drug product and drug substance, plus a multi-omics genetic testing and bioinformatics unit | Saudi ArabiaBiomanufacturing | Government biotechnology platformGovernment-owned | CommercialWholly owned by the Public Investment Fund. | Lifera | |
| SaudiBioModular aseptic fill-and-finish of biologics drug product, with sterile lines from Groninger, labelling and packaging from Bosch and modular build by KeyPlantsNext milestone: First commercial production | Saudi ArabiaBiopharmaceuticals | Government biotechnology platformGovernment-owned | Pre-commercialAcquired by Lifera. | Lifera | |
| Mubadala BioEssential medicines and, under the Biosidus agreement, endocrinology, nephrology and oncology biologicsExports: Reported as more than 100 countries | UAEBiopharmaceuticals | Government biotechnology platformGovernment-owned | CommercialWholly owned by Mubadala. | Licensed in, under the Biosidus agreement | Mubadala |
| Arcera Life SciencesVertically integrated pharmaceutical development, manufacture and commercialisationExports: Reported as 90-plus marketsScale figures as reported by Zawya, verified 22 September 2026. | UAEPharmaceuticals | Government biotechnology platformGovernment-owned | CommercialEstablished by ADQ. | TradingView carrying Zawya | |
| M42Population genomics, biobanking, precision diagnostics and AI-enabled health services | UAEGenomics and AI health | Government biotechnology platformGovernment-owned | CommercialFormed from Mubadala Health and G42 Healthcare. | M42 | |
| PureHealthHospital operations, laboratory diagnostics and health insuranceExports: United Kingdom | UAEDiagnostics and health services | Government biotechnology platformGovernment-owned | Commercial, listed on the Abu Dhabi Securities ExchangeListed. Acquisition consideration for Circle Health Group reported at $1.2bn. | PureHealth | |
| Gulf Pharmaceutical Industries (Julphar)Generic and branded pharmaceuticals, vaccines and consumer healthcareExports: International markets | UAEPharmaceuticals | Pharmaceutical manufacturerPrivately held | Commercial, listedListed on the Abu Dhabi Securities Exchange | Julphar | |
| WAYAKITBiotechnology-based disinfectant and cleaning products containing no toxic chemicals or oxidisersExports: Ground-handling agreements in foreign countries | Saudi ArabiaIndustrial biotechnology | University spinoutUniversity spinout | Commercial | KAUST | |
| MS PharmaBiologics manufacturing | Saudi ArabiaBiopharmaceuticals | Foreign company with Gulf operationsForeign-owned | Commercial | BioPharma APAC | |
| AumetAI marketplace connecting pharmaceutical suppliers and pharmaciesNext milestone: A disclosed follow-on round, or first revenue | GCCPharmaceutical distribution software | Gulf biotechnology developerPrivately held | Series A$12m Series A, closed | Arab News | |
| IMMUNORANovel peptide drugs combined with CAR-T cell therapy | Saudi ArabiaCell and gene therapy | Gulf biotechnology developerPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| Valere TherapeuticsPrecision immunotherapies for breast cancer | Saudi ArabiaBiopharmaceuticals | Gulf biotechnology developerPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| Nano BasedTargeted cell-nanoparticle immunotherapies | Saudi ArabiaBiopharmaceuticals | Gulf biotechnology developerPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| BioFiber SolutionsNanofibre wound care for diabetic foot wounds | Saudi ArabiaMedical technology | Gulf biotechnology developerPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| Revivo RxTopical broad-spectrum antibiotic spray | Saudi ArabiaBiopharmaceuticals | Gulf biotechnology developerPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| EpiNovaNon-invasive cancer diagnostics using AI | Saudi ArabiaDiagnostics | Diagnostics companyPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| Pro-GuardBiosensor for viral infection detection | Saudi ArabiaDiagnostics | Diagnostics companyPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| Biotechnology Innovation CompanyVaccine development with a stated focus on MERS | Saudi ArabiaVaccines | Gulf biotechnology developerPrivately held | Research and development | Saudi Biotechnology Accelerator | |
| ONOIDSPatient-derived tumour organoid platform | Saudi ArabiaOther biotechnology | Gulf biotechnology developerPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| AIDAbAI antibody design platform | Saudi ArabiaAI drug discovery | Gulf biotechnology developerPrivately held | Platform | Saudi Biotechnology Accelerator | |
| LigandoraAI biomolecule design platform | Saudi ArabiaAI drug discovery | Gulf biotechnology developerPrivately held | Platform | Saudi Biotechnology Accelerator | |
| Deep Medical Solutions AIAI chromosome and genetics analysis platform | Saudi ArabiaGenomics | Gulf biotechnology developerPrivately held | Platform | Saudi Biotechnology Accelerator | |
| Fitr FarmsAgricultural waste converted to mushrooms and mycelium products | Saudi ArabiaAgricultural biotechnology | Gulf biotechnology developerPrivately held | Commercial or early stage | Saudi Biotechnology Accelerator | |
| PhageTech SolutionBacteriophage products for poultry | Saudi ArabiaAgricultural biotechnology | Gulf biotechnology developerPrivately held | Commercial or early stage | Saudi Biotechnology Accelerator | |
| RedSea BioCollagenNative marine collagen for wound healing | Saudi ArabiaMedical technology | Gulf biotechnology developerPrivately held | Early stage | Saudi Biotechnology Accelerator | |
| Erada for Healthy LifeAI personalised nutrition built on genetic testing | Saudi ArabiaGenomics | Gulf biotechnology developerPrivately held | Commercial or early stage | Saudi Biotechnology Accelerator | |
| BioSapien | UAEMedical technology | Foreign company with Gulf operationsForeign-owned | Hub71 | ||
| Ovasave | UAEOther biotechnology | Gulf biotechnology developerPrivately held | Hub71 | ||
| BioTwinAI virtual human twin modelling applied to genomic and clinical data | UAEDiagnostics | Foreign company with Gulf operationsForeign-owned | Commercial pilot | Gulf News | |
| Saudi AmaroxCommercialisation and distribution under a CEL-SCI agreement | Saudi ArabiaBiopharmaceuticals | Distributor or ecosystem operatorPrivately held | Commercial | Business Wire | |
| Tamer GroupDistributes ethical branded pharmaceuticals, OTC and generics plus medical devices spanning diagnostic machines and reagents, interventional cardiology, radiology and orthopaedics to pharmacies and government and private hospitals. | Saudi ArabiaPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Tamer Group | |
| National Unified Procurement Company (NUPCO)National centralised procurement body purchasing, warehousing, distributing and re-exporting pharmaceuticals, medical devices and supplies for Saudi government healthcare facilities. | Saudi ArabiaPharmaceutical distribution | Distributor or ecosystem operatorGovernment-owned | Commercial | NUPCO | |
| SalehiyaDistributes pharmaceuticals, medical devices and diagnostics together with healthcare IT and supply-chain services across the Saudi market.Represents: Radiometer, Leica Biosystems, Beurer, HemoCue, Mindray | Saudi ArabiaPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Salehiya | |
| Abdullah Fouad for Medical Supplies and ServicesDistributes blood banking, core laboratory, molecular and point-of-care diagnostics, life-science research products, medical and surgical equipment, and nuclear medicine including radiopharmaceuticals and SPECT and PET imaging.Represents: Werfen, Grifols, Becton Dickinson, QIAGEN, DiaSorin, Thermo Scientific, Mindray, Sebia | Saudi ArabiaLaboratory diagnostics | Diagnostics companyPrivately held | Commercial | Abdullah Fouad for Medical Supplies and Services | |
| Cigalah HealthcareDistributes pharmaceutical and personal healthcare products from international manufacturers to private and government sectors in Saudi Arabia, including Gilead virology and oncology therapies.Represents: Gilead Sciences | Saudi ArabiaPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | World Health Expo (Informa) | |
| Nahdi Medical CompanyLargest retail pharmacy chain in Saudi Arabia, operating pharmacy retail, omnichannel fulfilment and NahdiCare polyclinics and virtual consultations.Covers: Saudi Arabia, UAE | Saudi ArabiaHealthcare services | Healthcare or laboratory operatorListed | Commercial, listed | Nahdi Medical Company Investor Relations | |
| Abdulrehman Algosaibi G.T.C. Medical and Scientific DivisionSupplies specialised medical equipment, disposables, hospital supplies, medical gas, laboratory, critical care and scientific equipment to the Saudi healthcare sector on behalf of multinational principals. | Saudi ArabiaMedical technology | Distributor or ecosystem operatorPrivately held | Commercial | Abdulrehman Algosaibi G.T.C. | |
| Al Faisaliah Medical Systems (FMS)Integrated healthcare solutions provider delivering medical consumables, equipment and turnkey healthcare projects across Saudi Arabia.Emerging signal, verification in progressProfiled in its parent group's portfolio. | Saudi ArabiaMedical technology | Distributor or ecosystem operatorPrivately held | Commercial | Al Faisaliah Group | |
| Gulf Drug LLCDistributes pharmaceuticals, medical equipment, medical supplies and instruments, and veterinary healthcare products as a business-to-business agent for international manufacturers. | UAEPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Gulf Drug LLC | |
| Modern Pharmaceutical CompanyDistributes pharmaceuticals, personal care, medical devices and diagnostic equipment through three units, supplying around a quarter of the UAE's pharmaceutical needs.Represents: Pfizer, AstraZeneca, Novartis, Sanofi, Janssen, Medtronic, Johnson & Johnson, Siemens, Beckman Coulter | UAEPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Albatha Group | |
| Zahrawi GroupDistributes surgical and cardiovascular equipment, medical devices and imaging systems, diagnostic and analytical laboratory equipment, and nuclear medicine and radiotherapy supplies from over two hundred international brands.Represents: Medtronic, Becton Dickinson, Smith & Nephew, Johnson & Johnson Vision, Sysmex, Agilent Technologies, Cepheid, Sakura, Boston Scientific, FujiFilmCovers: UAE, Saudi Arabia, Qatar, Bahrain, OmanEmerging signal, verification in progressPan-Gulf footprint across five markets, three corroborated by a partner release. | UAEMedical technology | Distributor or ecosystem operatorPrivately held | Commercial | Zahrawi Group | |
| Pharmatrade LLCDistributes over five thousand medical and pharmaceutical items from more than thirty multinational companies through pharmaceutical, medical and laboratory divisions to hospitals, clinics, laboratories, diagnostic centres and retail pharmacies. | UAEPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Pharmatrade LLC | |
| Genpharm ServicesProvides market access and commercial partnership for multinational rare disease and specialty care therapeutics across the Gulf.Represents: Rhythm PharmaceuticalsCovers: Saudi Arabia, UAE, Kuwait, Qatar, Oman, Bahrain | UAEPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Rhythm Pharmaceuticals investor relations | |
| Al Hayat PharmaceuticalsDistributes pharmaceuticals from multinational manufacturers to pharmacies, health centres, hospitals and private institutions across the UAE.Represents: Hikma Pharmaceuticals, Grifols, Orion Pharma, Tillotts Pharma, Dr. Wild & Company, Jerash Pharmaceuticals, Laboratoires Urgo Healthcare | UAEPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Al Hayat Pharmaceuticals | |
| Ebn Sina MedicalDistributes pharmaceuticals, medical equipment, hospital sundries, dental products and medicated cosmetics in Qatar, including BeiGene oncology medicines, and operates a retail pharmacy chain.Represents: BeiGene | QatarPharmaceutical distribution | Distributor or ecosystem operatorListed | Commercial, listed | Aamal Company Q.P.S.C. | |
| Ali Bin Ali MedicalImports and distributes medical and surgical equipment, sports and physiotherapy equipment, dental and laboratory equipment, hospital and laboratory furniture, consumables and pharmaceuticals. | QatarMedical technology | Distributor or ecosystem operatorPrivately held | Commercial | Ali Bin Ali Group | |
| Mannai HealthcareDistributes medical devices and healthcare equipment, laboratory solutions including chemicals, reagents, imaging and testing systems, and healthcare and laboratory information systems.Emerging signal, verification in progressSourced to the company's healthcare division page. | QatarMedical technology | Distributor or ecosystem operatorListed | Commercial, listed | Mannai Corporation QPSC | |
| YIACO Medical CompanyBegan as a marketing agent for multinational pharmaceutical manufacturers and now distributes pharmaceuticals, hospital and patient care supplies, home medical equipment, and animal health products, and runs a retail pharmacy group and medical centre. | KuwaitPharmaceutical distribution | Distributor or ecosystem operatorListed | Commercial, listed | YIACO Medical Company | |
| Advanced Technology Company K.S.C.P. (ATC)Healthcare technology provider distributing medical equipment across ten divisions including dental, biomedical, laboratory, pharmacy and security applications, and delivering turnkey healthcare facility projects.Emerging signal, verification in progressPrincipal relationships as described in a 2016 company profile. | KuwaitMedical technology | Distributor or ecosystem operatorListed | Commercial, listed | EME Outlook | |
| Ali Abdulwahab Al Mutawa Commercial Co.Distributes medications, dermocosmetic and skin care brands and professional medical equipment in Kuwait, and operates a retail pharmacy chain across the governorates.Represents: Roche, Bioderma, NUXE Paris, Institut Esthederm Paris, Bio-Oil, Caudalie Paris | KuwaitPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Ali Abdulwahab Al Mutawa Commercial Co. | |
| Bahrain Pharmacy and General StoreDiversified healthcare distributor supplying pharmaceuticals, medical devices and consumer health products to institutional and hospital markets, and operating seventeen retail pharmacy outlets across Bahrain.Represents: Sanofi, GSK, Pfizer, Novartis, Merck, Bayer, Abbott, Fujifilm, Mindray, Medtronic, Becton Dickinson, BIOTRONIK, Carestream Dental | BahrainPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Bahrain Pharmacy | |
| Gulf Corporation for TechnologyDistributes laboratory, diagnostics, dental and radiology equipment alongside retail and wholesale pharmaceutical products, representing around one hundred and fifty international brands.Represents: Shimadzu, GE Healthcare, Laerdal, Hill-Rom | BahrainPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Gulf Corporation for Technology | |
| Behzad Medical Est.One of the first pharmaceutical distributors in Bahrain, operating distribution alongside showrooms and a retail pharmacy network. | BahrainPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Behzad Medical Est. | |
| Muscat Pharmacy and StoresDistributes pharmaceuticals, hospital and laboratory instruments and equipment, surgical products, veterinary products and consumer health goods, and runs Oman's largest retail pharmacy network.Covers: Oman, UAE | OmanPharmaceutical distribution | Distributor or ecosystem operatorPrivately held | Commercial | Zawawi Group | |
| Mustafa Sultan Science and Industry Co.Distributes medical and laboratory equipment including laboratory balances, blood bank products, cardiac surgery and cardiology equipment on behalf of global manufacturers. | OmanLaboratory diagnostics | Diagnostics companyPrivately held | Commercial | Mustafa Sultan Enterprises | |
| OmanmedSupplies medical equipment, surgical and general consumables, laboratory consumables and hospital furniture to government organisations, hospitals, clinics and laboratories across Oman.Emerging signal, verification in progressSourced to the company's own site. | OmanMedical technology | Distributor or ecosystem operatorPrivately held | Commercial | Omanmed | |
| SaudiVaxVaccine secondary packaging today, with filling and drug-substance capability staged behind itNext milestone: Commissioning of the filling facility, which would give the Kingdom its first domestic vaccine fill capability | Saudi ArabiaVaccines | Pharmaceutical manufacturerPrivately held | Pre-commercial | SaudiVax | |
| ArabioSecondary packaging and promotion of licensed vaccines, with in-house filling lines listed as capabilityNext milestone: Disclosed in-house fill output, which would move it from packager to manufacturer | Saudi ArabiaVaccines | Pharmaceutical manufacturerPrivately held | Commercial | Developing Countries Vaccine Manufacturers Network | |
| Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO)Generic and branded pharmaceutical manufacture across solid dose, liquids and semi-solidsNext milestone: Disclosed contract manufacturing revenue as a separate reporting line | Saudi ArabiaPharmaceuticals | Pharmaceutical manufacturerListed on the Saudi Exchange (2070) | Commercial, listedPublicly listed | SPIMACO | |
| Jamjoom PharmaPharmaceutical manufacture with a concentration in dermatology, ophthalmology and general medicineExports: Middle East; AfricaNext milestone: Disclosed contract manufacturing capacity offered to third parties | Saudi ArabiaPharmaceuticals | Pharmaceutical manufacturerListed on the Saudi Exchange (4015) | Commercial, listedPublicly listed | Jamjoom Pharma | |
| Avalon Pharma (Middle East Pharmaceutical Industries)Dermatological and cosmeceutical pharmaceutical manufactureNext milestone: Disclosed cosmeceutical output volumes or export destinations | Saudi ArabiaPharmaceuticals | Pharmaceutical manufacturerListed on the Saudi Exchange (4016) | Commercial, listedPublicly listed | Saudi Exchange | |
| Tabuk PharmaceuticalsPharmaceutical manufacture across therapeutic areas, with cross-border contract manufacturingNext milestone: Disclosed volumes under the Globalpharma agreement | Saudi ArabiaPharmaceuticals | Pharmaceutical manufacturerAstra Industrial Group | CommercialSubsidiary of a listed group | Tabuk Pharmaceuticals | |
| Boston Oncology ArabiaSterile injectable oncology manufacture, including cytotoxicsNext milestone: Disclosed capacity, or contract work taken on for third parties | Saudi ArabiaBiopharmaceuticals | Pharmaceutical manufacturerJoint venture | Commercial | Boston Oncology Arabia | |
| Riyadh PharmaGeneric pharmaceutical manufacture | Saudi ArabiaPharmaceuticals | Pharmaceutical manufacturerPrivately held | Commercial | Riyadh Pharma | |
| Dallah PharmaPharmaceutical manufacture | Saudi ArabiaPharmaceuticals | Pharmaceutical manufacturerDallah Al-Baraka Group | Commercial | Dallah Pharma | |
| GlobalpharmaPharmaceutical manufacture across solid dose and liquidsNext milestone: Disclosed volumes under the Tabuk agreement | UAEPharmaceuticals | Pharmaceutical manufacturerDubai Investments subsidiary | CommercialSubsidiary of a listed group | Globalpharma | |
| Pharmax PharmaceuticalsPharmaceutical manufacture with a published facility expansionNext milestone: Commissioning of the announced expansion | UAEPharmaceuticals | Pharmaceutical manufacturerPrivately held | Commercial | Pharmax Pharmaceuticals | |
| Qatar PharmaPharmaceutical manufacture | QatarPharmaceuticals | Pharmaceutical manufacturerPrivately held | Commercial | Qatar Pharma | |
| Kuwait Saudi Pharmaceutical Industries Company (KSPICO)Pharmaceutical manufacture | KuwaitPharmaceuticals | Pharmaceutical manufacturerMezzan Holding | CommercialSubsidiary of a listed group | Mezzan Holding | |
| Oman Pharmaceutical ProductsPharmaceutical manufacture | OmanPharmaceuticals | Pharmaceutical manufacturerPrivately held | Commercial | Oman Pharmaceutical Products Co. LLC | |
| Philex PharmaceuticalsPharmaceutical manufacture | OmanPharmaceuticals | Pharmaceutical manufacturerPrivately held | Commercial | Oman Observer | |
| Dhofar Pharmaceutical IndustriesPharmaceutical manufactureNext milestone: Disclosed output or export destinations | OmanPharmaceuticals | Pharmaceutical manufacturerPrivately held | CommercialA stated RO 15m investment in the plant | Oman Observer | |
| Bahraini International Medicine Manufacturing CompanyPharmaceutical manufacture | BahrainPharmaceuticals | Pharmaceutical manufacturerPrivately held | Commercial | Saudi Gazette | |
| Gulf BiotechInjectable manufacture under a National Health Regulatory Authority licenceNext milestone: GMP certification and the start of commercial production | BahrainBiopharmaceuticals | Pharmaceutical manufacturerPrivately held | Pre-commercial | News of Bahrain | |
| Lifera and National Resilience aseptic joint ventureAseptic pharmaceutical manufacturingNext milestone: A definitive agreement replacing the term sheet, and a named siteEmerging signal, verification in progress | Saudi ArabiaBiomanufacturing | Pharmaceutical manufacturerAnnounced joint venture between Lifera and National Resilience | Announced | National Resilience, Inc. | |
| Julphar Saudi biologics facilityBiologics manufactureNext milestone: Construction start, an investment figure, or a commissioning dateEmerging signal, verification in progress | Saudi ArabiaBiomanufacturing | Pharmaceutical manufacturerGulf Pharmaceutical Industries (Julphar) | Announced | Argaam | |
| WuXi Biologics Middle East CRDMO centreContract research, development and manufacturing for biologicsNext milestone: Construction start or a published capacity figureEmerging signal, verification in progress | QatarBiomanufacturing | Pharmaceutical manufacturerWuXi Biologics | Announced | WuXi Biologics | |
| Biopharmaceutical manufacturing campus, G42 and MubadalaBiopharmaceutical manufactureNext milestone: A named site, a capacity figure or a construction startEmerging signal, verification in progress | UAEBiomanufacturing | Pharmaceutical manufacturerG42 and Mubadala | Announced | G42 | |
| Hayat BiotechVaccine fill-finishNext milestone: A current update on plant output and product rangeEmerging signal, verification in progress | UAEVaccines | Pharmaceutical manufacturerJoint venture with a Chinese partner | Hayat Biotech | ||
| NeopharmaPharmaceutical manufactureNext milestone: A current update on ownership and operationsEmerging signal, verification in progress | UAEPharmaceuticals | Pharmaceutical manufacturer | Tracking | ||
| Hevolution FoundationGrant-making and impact investment in geroscience, ageing biology and healthspan therapeuticsNext milestone: A first Gulf-domiciled portfolio company, or a grant to a Gulf institution at portfolio scale | Saudi ArabiaLongevity and healthspan | Research funderSaudi non-profit, established by royal order | Commercial49 awards worth up to $115m over five years in the first cohort; $55m across four biotechnology companies announced in February 2025; a $20m lead in Aeovian's Series A extension; more than SAR1.5bn committed in total | Hevolution Foundation | |
| Institute for Healthier Living Abu DhabiPersonalised longevity medicine addressing ageing processes and chronic disease prevention across lifestyle, therapeutics, mental wellbeing and environmental factorsNext milestone: Published outcome data, a first for any longevity clinic | UAELongevity and healthspan | Longevity clinic | Commercial | Abu Dhabi Media Office | |
| Pura Longevity ClinicPersonalised longevity plans combining diagnostics, lifestyle assessment, nutrition, sleep medicine and fitnessNext milestone: Disclosed patient volumes or published outcome data | UAELongevity and healthspan | Longevity clinicPureHealth | Commercial | PureHealth | |
| Abu Dhabi Stem Cells CenterA virus-free protocol reprogramming adult somatic cells into GMP-grade clinical induced pluripotent stem cells without viral vectorsNext milestone: A clinical programme entering trials using its own iPSC lines | UAECell and gene therapy | Research instituteGovernment-owned | Commercial | Abu Dhabi Media Office | |
| Abu Dhabi BiobankHybrid public and private cord blood banking with automated cryogenic storage, integrated with clinical, genomic and real-world health dataNext milestone: Commissioning of the UC-MSC manufacturing pathway | UAECell and gene therapy | Research instituteDepartment of Health Abu Dhabi and M42 | Commercial | Abu Dhabi Media Office | |
| AD-OmicsSingle-cell sequencing and multi-omics with AI-based analysis to predict disease progressionNext milestone: A published laboratory location and service volumes | UAEGenomics | Diagnostics companyJoint venture between the Institute for Healthier Living Abu Dhabi and Singleron Biotechnologies | Commercial | Singleron Biotechnologies | |
| Hub71+ Life SciencesA life sciences cluster programme with regulatory and longevity partnersNext milestone: A first cohort with named companies and disclosed funding | UAEOther biotechnology | Distributor or ecosystem operatorHub71, an Abu Dhabi government programme | Commercial | Abu Dhabi Media Office | |
| KayaneeWomen's wellness, fitness and nutrition retail and servicesNext milestone: Own-brand formulation or manufacture | Saudi ArabiaPreventive and wellness services | Healthcare or laboratory operatorPublic Investment Fund | CommercialWholly owned by the Public Investment Fund. | Public Investment Fund | |
| Zulal Wellness ResortWellness programming combining traditional Arabic and Islamic medicine with conventional wellness practiceNext milestone: Clinical or research programming alongside hospitality wellness | QatarPreventive and wellness services | Longevity clinicOperated by Chiva-Som | Commercial | Hospitality Net | |
| Medytox Dubai Science Park facilityFinished botulinum toxin manufactureNext milestone: Construction start, investment or commissioningEmerging signal, verification in progress | UAEAesthetic and regenerative medicine | Pharmaceutical manufacturerMedytox | Announced | The Korea Economic Daily | |
| HELMA longevity initiative spanning health, endurance and medicineNext milestone: A published mandate, budget or first programmeEmerging signal, verification in progress | UAELongevity and healthspan | Distributor or ecosystem operatorAbu Dhabi government initiative | Announced | Longevity.Technology | |
| Clinique La Prairie AMAALALongevity and preventive health programmes within a destination developmentNext milestone: An opening date, or a published clinical scope and licensing basisEmerging signal, verification in progress | Saudi ArabiaPreventive and wellness services | Longevity clinicClinique La Prairie | Announced | Clinique La Prairie | |
| Medica GroupDistribution of aesthetic injectablesRepresents: HugelNext milestone: A published principal list and market coverageEmerging signal, verification in progress | UAEAesthetic and regenerative medicine | Distributor or ecosystem operatorPrivately held | Commercial | PR Newswire |
Gulf biotechnology reaching global markets
Gulf-owned or Gulf-developed capability reaching markets outside the GCC.
Every entry is a verified outbound achievement, and the dataset grows as Gulf capability reaches new markets. Next milestones to watch: international licensing out, overseas regulatory approval, international patents and international clinical partnerships.
Data table
| Date | Entity and detail | Route | Evidence | Value | Source |
|---|---|---|---|---|---|
| 14 January 2024 | PureHealthAcquisition of Circle Health Group, the largest private hospital operator in the United Kingdom, completed January 2024. | UAE to United Kingdom | Outbound acquisitionHealth services | AED 4.41bn, stated by the acquirer as $1.2bn | PureHealth |
| 14 January 2024 | PureHealthAn equity stake in Ardent Health Services, disclosed by PureHealth in the same release that confirmed the Circle Health Group completion. | UAE to United States | Outbound acquisitionHealth services | AED 1.8bn equity stake | PureHealth |
| 13 September 2026 | PureHealthTakeover of selected Unilabs UK laboratory operations, including hub laboratories at Euston and Cavendish Square in London, serving more than 50 hospitals and more than 90 external healthcare clients. | UAE to United Kingdom | Outbound acquisitionLaboratory diagnostics | Gulf News | |
| 19 September 2023 | WAYAKITA KAUST spinout with ground-handling agreements in foreign countries alongside its nationwide Saudi Ground Services contract. | Saudi Arabia to international markets | Gulf-developed technology adopted abroadIndustrial biotechnology | KAUST | |
| May 2025 | Mubadala BioOperates 10 facilities, 6 of them in the Emirates and the remainder across Asia, Africa and Europe, with medicines reaching more than 100 countries. | UAE to Asia, Africa and Europe | Foreign manufacturing agreementsBiopharmaceuticals | Mubadala | |
| 2025 | Arcera Life SciencesReported to develop and commercialise more than 2,000 medicines across more than 90 markets, with manufacturing in eight countries.Reported via Zawya, verified 22 September 2026. | UAE to Reported as 90-plus markets | Exported productsPharmaceuticals | TradingView carrying Zawya |